新城发展(01030.HK):拟通过配售股份筹资27.3亿港元
格隆汇1月14日丨新城发展(01030.HK)公布,于2019年1月14日,公司拟向不少于6名投资者配售最多3.11亿股,占经扩大后公司股份5.01%。配售价为每股8.78港元,较昨日收市价每股9.05港元折让约2.98%。预期所得款项总额将约为27.31亿港元及所得款项净额约为27.11亿港元。
公告称,进行配售事项旨在补充集团长期扩张及成长计划的所需资金。董事认为,配售事项将为公司提供一个筹集更多资金的机会,同时拓宽其股东基础,优化其资本结构,并为集团提供资金以满足未来可能的发展。假设全部配售股份均已根据配售协议获悉数配售,公司拟将所有配售事项估计所得款项净额用公司长远的业务发展,以及作为集团的一般营运资金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.